ArticleNeuroradiology2026
Flow-sensitive black blood sequence in evaluating impairment of cerebral venous drainage in patients with intracranial dural arteriovenous fistulas.
Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeIntracranial dural arteriovenous fistulas (DAVFs) sometimes cause impaired cerebral venous drainage (ICVD), leading to severe neurological outcomes. While digital subtraction angiography (DSA) is the diagnostic gold standard, the assessment of ICVD through the “pseudophlebitic pattern (PPP)” can be subjective and difficult. This study aimed to evaluate the utility of the flow-sensitive black-blood (FSBB) MRI sequence for detecting ICVD in DAVF patients by comparing it with findings from cerebral angiography. MATERIALS AND
methodsWe retrospectively analyzed 25 patients with DAVFs who underwent both FSBB MRI and DSA. Two radiologists, an experienced neuroradiologist and a radiology resident, independently evaluated the images. ICVD on FSBB was defined as dilated and tortuous venous structures. Interobserver agreement was calculated using the κ statistic.
resultsFSBB MRI identified signs of ICVD more frequently than DSA revealed PPP for both the neuroradiologist (76% vs. 64%) and the resident (68% vs. 48%). Importantly, interobserver agreement for detecting these findings was higher with FSBB (κ = 0.72) than with angiography (κ = 0.61). FSBB also detected ICVD in cases that were negative for PPP on angiography, suggesting higher sensitivity. Furthermore, of 14 patients who underwent post-treatment imaging, 12 (87.5%) showed improvement in ICVD findings on FSBB, suggesting its utility in monitoring treatment response.
conclusionFSBB MRI is a highly sensitive and reproducible technique for evaluating ICVD in patients with DAVFs.
Indexed as
Identifiers
41632266What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.